Genetic Variants in ABO Blood Group Region, Plasma Soluble E-selectin Levels and Risk of Type 2 Diabetes
Overview
Molecular Biology
Authors
Affiliations
Blood soluble E-selectin (sE-selectin) levels have been related to various conditions such as type 2 diabetes. We performed a genome-wide association study among women of European ancestry from the Nurses' Health Study, and identified genome-wide significant associations between a cluster of markers at the ABO locus (9q34) and plasma sE-selectin concentration. The strongest association was with rs651007, which explained approximately 9.71% of the variation in sE-selectin concentrations. SNP rs651007 was also nominally associated with soluble intracellular cell adhesion molecule-1 (sICAM-1) (P = 0.026) and TNF-R2 levels (P = 0.018), independent of sE-selectin. In addition, the genetic-inferred ABO blood group genotypes were associated with sE-selectin concentrations (P = 3.55 x 10(-47)). Moreover, we found that the genetic-inferred blood group B was associated with a decreased risk (OR = 0.44, 0.27-0.70) of type 2 diabetes compared with blood group O, adjusting for sE-selectin, sICAM-1, TNF-R2 and other covariates. Our findings indicate that the genetic variants at ABO locus affect plasma sE-selectin levels and diabetes risk. The genetic associations with diabetes risk were independent of sE-selectin levels.
Association of blood group types and clinico-pathological features of gynecological cancers (GCs).
Aga S, Khan M, Al Mansour M, Hasosah R, Alsubaie L, Alfaify D BMC Cancer. 2025; 25(1):137.
PMID: 39849419 PMC: 11760766. DOI: 10.1186/s12885-025-13527-z.
Shi H, Yao J, Jiang C, Xu W, Jiang Z, Chen Y BMJ Open. 2024; 14(10):e088016.
PMID: 39414296 PMC: 11481122. DOI: 10.1136/bmjopen-2024-088016.
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?.
Uy G, DeAngelo D, Lozier J, Fisher D, Jonas B, Magnani J Blood Rev. 2024; 65:101184.
PMID: 38493006 PMC: 11051645. DOI: 10.1016/j.blre.2024.101184.
Karaoglan B, Akyol C, Unal A, Kuzu A, Savas B, Utkan G J Gastrointest Cancer. 2023; 55(1):281-286.
PMID: 37414939 DOI: 10.1007/s12029-023-00958-9.
An atlas of genetic scores to predict multi-omic traits.
Xu Y, Ritchie S, Liang Y, Timmers P, Pietzner M, Lannelongue L Nature. 2023; 616(7955):123-131.
PMID: 36991119 PMC: 10323211. DOI: 10.1038/s41586-023-05844-9.